Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank

Thirty Clostridioides difficile isolates collected in 2016 through the Centers for Disease Control and Prevention Emerging Infections Program were selected for reference antimicrobial susceptibility testing and whole-genome sequencing. Here, we present the genetic characteristics of these isolates a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulick, Ashley, Adamczyk, Michelle, Anderson, Karen, Vlachos, Nick, Machado, María-José, McAllister, Gillian, Korhonen, Lauren, Guh, Alice Y., Halpin, Alison Laufer, Rasheed, J. Kamile, Karlsson, Maria, Lutgring, Joseph D., Gargis, Amy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Culture Collections/Mutant Libraries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407687/
https://www.ncbi.nlm.nih.gov/pubmed/33414286
http://dx.doi.org/10.1128/MRA.01011-20
Descripción
Sumario:Thirty Clostridioides difficile isolates collected in 2016 through the Centers for Disease Control and Prevention Emerging Infections Program were selected for reference antimicrobial susceptibility testing and whole-genome sequencing. Here, we present the genetic characteristics of these isolates and announce their availability in the CDC & FDA Antibiotic Resistance Isolate Bank.

Ejemplares similares